Research programme: GABA A subtype receptor modulators - Dart NeuroScience

Drug Profile

Research programme: GABA A subtype receptor modulators - Dart NeuroScience

Alternative Names: GABA-A Program - Dart NeuroScience; HT-2678; HT-4313

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Helicon Therapeutics
  • Developer Dart NeuroScience
  • Class Pyrazoles; Pyridines; Quinolines; Small molecules
  • Mechanism of Action GABA A receptor inverse agonists; GABA A receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cognition disorders

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for research development in Cognition-disorders in USA
  • 01 Jan 2012 Helicon Therapeutics has been acquired and merged into Dart NeuroScience
  • 31 Mar 2011 Early research in Cognition disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top